ORGO today
$0.97-$0.08 (-7.29%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourBearish
15 minBearish
5 minStrong Bearish
Daily trend turns up above $1.39
Key levels
Resistance$1.39
Resistance$1.27
Support$0.91
Support$0.75
Latest news & SEC filings
EarningsOrganogenesis Holdings Posts Q3 2026 Results
EarningsOrganogenesis Holdings holds Q3 2026 earnings call
EarningsOrganogenesis posts Q3 adjusted loss per share of $0.25, revenue of $45.46M
SEC FilingOrganogenesis Holdings Inc. filed a report on a major company event (Form 8-K)
GuidanceOrganogenesis Narrows FY2026 Sales Guidance to $179.4M-$200M
All ORGO news →About Organogenesis
Organogenesis is a regenerative medicine company that develops, manufactures, and sells products for advanced wound care and surgical and sports medicine. Its products include skin substitutes and placental allografts such as Apligraf, PuraPly, Affinity, and NuShield. Customers include hospitals, wound care centers, surgery centers, physician offices, and government facilities, primarily in the United States.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
Organogenesis Holdings Inc. (ORGO)
What Is the Price Target for ORGO?
SEPT Low Target
$2.00
SEPT Mid Target
$2.00
SEPT High Target
$2.00
Analyst Consensus
$2.00
Is ORGO a Buy or Sell Right Now?
Thesis
- •Revenue growing 17.0% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ORGO.
Start Free Trial →Is ORGO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$2.25
22
Moat Score
NONE
3/9
Piotroski Score
2.1
Altman Z-Score
What Is Smart Money Doing with ORGO?
Insider Signal
NEUTRAL
2 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ORGO Growth Story
Revenue YoY
17.0%
3yr Revenue CAGR
7.8%
EPS Growth YoY
1600%
FCF Growth YoY
-685.7%
Revenue Trend
ACCELERATING
Dark Pool Trades for ORGO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ORGO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:34:37 | $0.97 | 1,900 | $$2K | SELL |
| 19:34:37 | $0.97 | 1,100 | $$1K | SELL |
| 19:34:37 | $0.97 | 1,900 | $$2K | BUY |
| 19:34:37 | $0.97 | 1,900 | $$2K | SELL |
| 19:31:27 | $0.98 | 1,000 | $$977 | SELL |
5 dark pool trades shown · $$8K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Organogenesis Holdings Inc. (ORGO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ORGO — frequently asked questions
What is ORGO stock price today?
Organogenesis Holdings Inc. (ORGO) is at $0.97, down 7.29% (-$0.08) at the Nov 12, 2026 close.
Why is ORGO stock moving today?
Latest ORGO news — Nov 6, 2026: Organogenesis Holdings Posts Q3 2026 Results · Nov 5, 2026: Organogenesis Holdings holds Q3 2026 earnings call
What is the ORGO price target?
The average analyst price target for ORGO is $2.00, ranging from $2 to $2, based on 1 analysts. Latest: Truist Securities maintains on Aug 7, 2026.
What do analysts rate ORGO?
Analyst ratings for ORGO: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did ORGO beat earnings?
ORGO last reported on Aug 6, 2026: EPS -$0.71 vs -$0.35 expected — a miss of 102.9%.
Does ORGO pay a dividend?
Yes. ORGO's dividend yield is 1.73%.
What are ORGO support and resistance levels?
Support: $0.91, $0.75. Resistance: $1.27, $1.39, $1.50.
What are insiders doing with ORGO?
Insider activity: NEUTRAL, 2 buys and 0 sells in the last 90 days.
What is the latest news on ORGO?
Nov 6, 2026: Organogenesis Holdings Posts Q3 2026 Results · Nov 5, 2026: Organogenesis Holdings holds Q3 2026 earnings call · Nov 5, 2026: Organogenesis posts Q3 adjusted loss per share of $0.25, revenue of $45.46M